Recruiting
Phase 2

SGLT2i & GLP-1RA

Sponsor:

University Health Network, Toronto

Code:

NCT04535960

Conditions

Type 2 Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Empagliflozin 25 MG + Liraglutide 1.8 MG

Liraglutide 1.8 MG + Empagliflozin 25 MG

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information